Accessibility Menu
Avanos Medical Stock Quote

Avanos Medical (NYSE: AVNS)

$11.59
(-1.4%)
-0.17
Price as of October 21, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$11.59
Daily Change
(-1.4%) $0.17
Day's Range
$11.51 - $11.8
Previous Close
$11.59
Open
$11.78
Beta
0.94
Volume
308,194
Average Volume
634,286
Market Cap
545.7M
Market Cap / Employee
$11.76M
52wk Range
$9.3 - $22.86
Revenue
-
Gross Margin
0.54%
Dividend Yield
N/A
EPS
-$10.06
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Avanos Medical Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
AVNS-49.57%-68.35%-20.56%-70%
S&P+14.84%+96.04%+14.41%+249%

Avanos Medical Company Info

Avanos Medical, Inc. is a medical technology company. It engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$175.00M1.9%
Gross Profit$92.10M-3.7%
Gross Margin52.63%-3.0%
Market Cap$566.03M-38.1%
Market Cap / Employee$0.25M0.0%
Employees2.2K-40.9%
Net Income-$76.80M-1886.0%
EBITDA$17.30M-36.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$90.30M-2.1%
Accounts Receivable$110.00M-10.5%
Inventory142.7-12.9%

Liabilities

Q2 2025YOY Change
Long Term Debt$117.50M-39.3%
Short Term Debt$19.80M-19.5%

Ratios

Q2 2025YOY Change
Return On Assets-34.21%-34.6%
Return On Invested Capital-8.04%-7.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$4.20M-119.2%
Operating Free Cash Flow$6.80M-75.5%

Valuation

MetricQ2 2024Q3 2024YoY Change
Price to Earnings120.0071.24-
Price to Book0.900.590.800.67-9.78%
Price to Sales1.641.060.970.82-39.45%
Price to Tangible Book Value5.483.412.532.05-55.31%
Price to Free Cash Flow TTM30.608.835.886.45-70.78%
Enterprise Value to EBITDA43.4233.6842.2835.47-7.29%
Free Cash Flow Yield3.3%11.3%17.0%15.5%242.23%
Return on Equity1.8%-37.4%-36.8%-46.2%-8202.04%
Total Debt$202.20M$170.20M$140.90M$137.30M-37.10%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.